glp 1 plotter GLP-1 Tracker Schematic representation of production of

Considerations for Anyone Evaluating GLP-1 Telehealth Access: Compounded medications are not FDA-approved: Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed

The regulatory environment for compounded GLP-1 products has tightened significantly in 2026

37 Empagliflozin EMA product information (2023)

[DOI] [PubMed] [Google Scholar] 109.Bartholdy K.V., Johansen N.D., Skaarup K.G., Modin D., Landler N., Langhoff A.F., Ottosen C.:I., Espersen C., Dons M., Borchsenius J.I.M., et al

Instead of HR teams having to liaise with multiple wellness providers, stipends let employees choose what works for them within a defined budget